Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
The Journal of Antimicrobial Chemotherapy
|
September 21, 2020
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response
Christine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
Hemasphere
|
January 18, 2021
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study
Marie-Dominique Tabone, Sami Kolta, Pascal Auquier, et al.
Joint Bone Spine
|
April 24, 2012
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
Karine Briot, Bernard Cortet, Thierry Thomas, et al.
RMD Open
|
February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
Peter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.
Joint Bone Spine
|
April 8, 2014
Usefulness of bone density measurement in fallers
Hubert Blain, Yves Rolland, Olivier Beauchet, et al.
Nature Medicine
|
September 28, 2023
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
The Journal of Antimicrobial Chemotherapy
|
September 21, 2020
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response
Christine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
Hemasphere
|
January 18, 2021
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study
Marie-Dominique Tabone, Sami Kolta, Pascal Auquier, et al.
Joint Bone Spine
|
April 24, 2012
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
Karine Briot, Bernard Cortet, Thierry Thomas, et al.
RMD Open
|
February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
Peter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.
Joint Bone Spine
|
April 8, 2014
Usefulness of bone density measurement in fallers
Hubert Blain, Yves Rolland, Olivier Beauchet, et al.
Nature Medicine
|
September 28, 2023
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo, et al.
Page
of 5